Clinical Trial Update: Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for CT-01 in intermediate or advanced hepatocellular carcinoma shows the study is currently NOT_YET_RECRUITING, evaluating CT-01…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CT-01

Snippet

Sponsor: Captor Therapeutics S.A. | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1 | Status: NOT_YET_RECRUITING